SpeakEasy Cannabis Club Ltd. announced it is 4 months into a 6-9 month application process to receiving its Narcotics Dealers License in-order to develop and standardize psilocybin cultivation. A NDL licenced dealer may produce, assemble, sell, provide, transport, send, deliver, import or export a controlled drug (psilocybin) if they comply with the terms and conditions of their dealer's licence and any permit issued under the licence. SpeakEasy's Narcotics Dealers Licence: In early January this year, the company has began the application process for an NDL and a section of SpeakEasy's processing building has been earmarked as the location for the research and development area that would house a licence referred to as an NDL. The NDL allows research, development, purchase and sales among other activities of narcotics. SpeakEasy's intent is to acquire a full catalogue of psilocybin bearing mushroom genetics in-order to develop cultivation methods, standardize potency and develop extracted concentrated products in preparation and with the expectation of the legalization of psilocybin in the Canadian market. The company expects to complete the extensive review process and receive its NDL later this year with the total Licensing process taking between six and nine months. Upon receipt, the Company intends to immediately begin the process of preparing for the anticipation of the legal market.